These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 33718978)

  • 1. Compliance with mismatch repair testing in pT1 colorectal cancer diagnosed before the age of 70 years.
    Ykema BLM; Nagtegaal ID; Kuhlmann K; van Berkel AM; van Leerdam ME;
    Virchows Arch; 2021 Sep; 479(3):451-457. PubMed ID: 33718978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of tumor morphology with mismatch-repair protein status in older endometrial cancer patients: implications for universal versus selective screening strategies for Lynch syndrome.
    Rabban JT; Calkins SM; Karnezis AN; Grenert JP; Blanco A; Crawford B; Chen LM
    Am J Surg Pathol; 2014 Jun; 38(6):793-800. PubMed ID: 24503759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical evaluation of mismatch repair proteins in colorectal carcinoma: the AIFEG/GIPAD proposal.
    Remo A; Fassan M; Lanza G
    Pathologica; 2016 Sep; 108(3):104-109. PubMed ID: 28195261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathologic Comparison of Lynch Syndrome-associated and "Lynch-like" Endometrial Carcinomas Identified on Universal Screening Using Mismatch Repair Protein Immunohistochemistry.
    Mills AM; Sloan EA; Thomas M; Modesitt SC; Stoler MH; Atkins KA; Moskaluk CA
    Am J Surg Pathol; 2016 Feb; 40(2):155-65. PubMed ID: 26523542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The histomorphology of Lynch syndrome-associated ovarian carcinomas: toward a subtype-specific screening strategy.
    Chui MH; Ryan P; Radigan J; Ferguson SE; Pollett A; Aronson M; Semotiuk K; Holter S; Sy K; Kwon JS; Soma A; Singh N; Gallinger S; Shaw P; Arseneau J; Foulkes WD; Gilks CB; Clarke BA
    Am J Surg Pathol; 2014 Sep; 38(9):1173-81. PubMed ID: 25025451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of immunohistochemical mismatch repair protein status between colorectal carcinoma endoscopic biopsy and resection specimens.
    O'Brien O; Ryan É; Creavin B; Kelly ME; Mohan HM; Geraghty R; Winter DC; Sheahan K
    J Clin Pathol; 2018 Jul; 71(7):631-636. PubMed ID: 29419411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consequences of testing for mismatch repair deficiency of colorectal cancer in clinical practice.
    Leicher LW; Lammertink MHA; Offerman SR; Morreau H; de Jong MM; de Groot JWB; van Westreenen HL; Vasen HFA; de Vos Tot Nederveen Cappel WH
    Scand J Gastroenterol; 2018 May; 53(5):632-636. PubMed ID: 29161904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncology and Gynecologic Oncology Group Study.
    Goodfellow PJ; Billingsley CC; Lankes HA; Ali S; Cohn DE; Broaddus RJ; Ramirez N; Pritchard CC; Hampel H; Chassen AS; Simmons LV; Schmidt AP; Gao F; Brinton LA; Backes F; Landrum LM; Geller MA; DiSilvestro PA; Pearl ML; Lele SB; Powell MA; Zaino RJ; Mutch D
    J Clin Oncol; 2015 Dec; 33(36):4301-8. PubMed ID: 26552419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of endometrial cancer abnormal MMR protein in screening Lynch-syndrome families.
    Long Q; Peng Y; Tang Z; Wu C
    Int J Clin Exp Pathol; 2014; 7(10):7297-303. PubMed ID: 25400828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular analysis of Iranian colorectal cancer patients at risk for Lynch syndrome: a new molecular, clinicopathological feature.
    Zeinalian M; Emami MH; Salehi R; Naimi A; Kazemi M; Hashemzadeh-Chaleshtori M
    J Gastrointest Cancer; 2015 Jun; 46(2):118-25. PubMed ID: 25722176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Universal Lynch Syndrome Screening Should be Performed in All Upper Tract Urothelial Carcinomas.
    Ju JY; Mills AM; Mahadevan MS; Fan J; Culp SH; Thomas MH; Cathro HP
    Am J Surg Pathol; 2018 Nov; 42(11):1549-1555. PubMed ID: 30148743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Lynch syndrome among patients with colorectal cancer.
    Moreira L; Balaguer F; Lindor N; de la Chapelle A; Hampel H; Aaltonen LA; Hopper JL; Le Marchand L; Gallinger S; Newcomb PA; Haile R; Thibodeau SN; Gunawardena S; Jenkins MA; Buchanan DD; Potter JD; Baron JA; Ahnen DJ; Moreno V; Andreu M; Ponz de Leon M; Rustgi AK; Castells A;
    JAMA; 2012 Oct; 308(15):1555-65. PubMed ID: 23073952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility of screening for Lynch syndrome among patients with colorectal cancer.
    Hampel H; Frankel WL; Martin E; Arnold M; Khanduja K; Kuebler P; Clendenning M; Sotamaa K; Prior T; Westman JA; Panescu J; Fix D; Lockman J; LaJeunesse J; Comeras I; de la Chapelle A
    J Clin Oncol; 2008 Dec; 26(35):5783-8. PubMed ID: 18809606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lynch syndrome and Lynch syndrome mimics: The growing complex landscape of hereditary colon cancer.
    Carethers JM; Stoffel EM
    World J Gastroenterol; 2015 Aug; 21(31):9253-61. PubMed ID: 26309352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of DNA mismatch repair protein expression for primary and recurrent colorectal cancer at an advanced surgical unit: A retrospective audit.
    Risbey C; Fielder T; Steffens D; Shin JS; Solomon M
    Colorectal Dis; 2023 Mar; 25(3):369-374. PubMed ID: 36300681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interpretation of immunohistochemistry for mismatch repair proteins is only reliable in a specialized setting.
    Overbeek LI; Ligtenberg MJ; Willems RW; Hermens RP; Blokx WA; Dubois SV; van der Linden H; Meijer JW; Mlynek-Kersjes ML; Hoogerbrugge N; Hebeda KM; van Krieken JH
    Am J Surg Pathol; 2008 Aug; 32(8):1246-51. PubMed ID: 18677806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of yield and experiences of age-related molecular investigation for heritable and nonheritable causes of mismatch repair deficient colorectal cancer to identify Lynch syndrome.
    Vos JR; Fakkert IE; Spruijt L; Willems RW; Langenveld S; Mensenkamp AR; Leter EM; Nagtegaal ID; Ligtenberg MJL; Hoogerbrugge N;
    Int J Cancer; 2020 Oct; 147(8):2150-2158. PubMed ID: 32510614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mismatch Repair Screening of Gastrointestinal Cancers: The Impact on Lynch Syndrome Detection and Immunotherapy.
    R OM; J W; T F; C M; A W; N S; Z K
    J Gastrointest Cancer; 2023 Sep; 54(3):768-775. PubMed ID: 36018445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experience of the implementation and outcomes of universal testing for Lynch syndrome in the United Kingdom.
    Cavazza A; Radia C; Harlow C; Monahan KJ
    Colorectal Dis; 2019 Jul; 21(7):760-766. PubMed ID: 30815953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Yield of routine molecular analyses in colorectal cancer patients ≤70 years to detect underlying Lynch syndrome.
    van Lier MG; Leenen CH; Wagner A; Ramsoekh D; Dubbink HJ; van den Ouweland AM; Westenend PJ; de Graaf EJ; Wolters LM; Vrijland WW; Kuipers EJ; van Leerdam ME; Steyerberg EW; Dinjens WN;
    J Pathol; 2012 Apr; 226(5):764-74. PubMed ID: 22081473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.